1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ten-year follow-up of pentostatin combined with cyclophosphamide, and rituximab in previously untreated indolent B-cell lymphoma
    Meeting Abstract

    Khashab, T.; Niaz, M. O.; Hagemeister, F. B.; Romaguera, J. E.; Fanale, M. A.; Pro, B.; McLaughlin, P.; Rodriguez, M. A.; Neelapu, S. S.; Fayad, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX
    Meeting Abstract

    Kelly, C. M.; Janjigian, Y. Y.; Kelsen, D. P.; Capanu, M.; Chou, J. F.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy
    Meeting Abstract

    Kaufman, H. L.; Russell, J.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma
    Meeting Abstract

    Grommes, C.; Stone, J.; Nolan, C.; Tsyvkin, E.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol
    Meeting Abstract

    Grupp, S. A.; Richardson, P. G.; Smith, A. R.; Triplett, B.; Kernan, N. A.; Antin, J. H.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma
    Meeting Abstract

    Gopalakrishnan, V.; Spencer, C.; Reuben, A.; Karpinets, T.; Hutchinson, D.; Hoffman, K.; Prieto, P. A.; Tetzlaff, M. T.; Lazar, A.; Davies, M. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors
    Meeting Abstract

    Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save